Slowing the progression of Parkinson's disease: is it possible?

Parkinson's disease is one of the most common neurodegenerative diseases in the world, affecting millions of people.

It manifests mainly with motor disturbances such as tremors, rigidity and slowness of movement, but can also include non-motor symptoms such as depression, cognitive problems and sleep disturbances. Parkinson's is a progressive disease, which means that symptoms tend to worsen over time.

However, one of the most common questions from patients and their families is: “Is it possible to slow the progression of Parkinson's disease?”. Although there is currently no definitive cure, there are promising strategies that aim to slow its course. These include lifestyle changes, drug therapies, and innovative approaches such as peripheral mechanical stimulation.

In this article we will explore the options available to slow the progression of Parkinson's disease and improve patients' quality of life.

What is Parkinson's disease?

Parkinson's is a disease of the central nervous system caused by the degeneration of neurons which produce dopamine, a neurotransmitter essential for movement control. Dopamine deficiency leads to a range of motor symptoms, including tremors, muscle rigidity, slowness of movement (bradykinesia) and postural instability.

Although the precise causes of Parkinson's are still unknown, a combination of genetic and environmental factors appear to contribute to the onset of the disease. While some individuals may inherit a genetic predisposition, most cases are idiopathic, meaning without an identifiable cause.

In recent years, research has made significant progress in understanding the disease, paving the way for the development of more effective treatments.

Drug treatments: what options exist today?

Treatment of Parkinson's disease relies mainly on symptom management through drugs that increase dopamine levels in the brain or enhance their effectiveness. The most commonly used drug is the levodopa, a dopamine precursor that is converted to dopamine once it reaches the brain. Levodopa is effective in reducing motor symptoms, but over time it can lose some of its effectiveness, leading to fluctuations in symptoms. To compensate, doses of the drug are often increased, which, in the long run, can cause involuntary movements known as dyskinesias.

In addition to levodopa, there are other classes of drugs used to treat Parkinson's, including dopamine agonists and MAO-B inhibitors., which slow the degradation of dopamine. However, a fast-growing area of research is the neuroprotective drugs, i.e., therapies that not only alleviate symptoms but could protect neurons from degeneration and potentially slow disease progression. Although no neuroprotective drug has yet been approved with certainty, some preliminary studies of drugs such as rasagilene (an MAO-B inhibitor) and dopamine agonists have shown promising results.

The importance of exercise in the management of Parkinson's disease

One of the most effective nonpharmacological interventions for patients with Parkinson's disease is exercise. Several scientific studies have shown that regular physical activity can improve motor function, reduce non-motor symptoms, and improve patients' quality of life. But what makes exercise particularly interesting is its effect on the neuroplasticity, or the brain's ability to adapt and reorganize. Exercise stimulates the release of neurotrophic factors, such as the BDNF (Brain-Derived Neurotrophic Factor), which promote the survival and growth of neurons. This could have a protective effect on the brain and, therefore, potentially slow the progression of the disease.

The studies of Wittenberg (2009) e Reid et al. (2015) have shown how neuroplasticity can be activated through exercise, improving motor response and promoting brain adaptation. Exercise should not be intensive, but rather targeted and consistent. Recommended activities include balance, flexibility and resistance exercises such as tai chi, Pilates, yoga, walking and swimming, which help improve coordination and posture, reducing the risk of falls, a common problem in patients with Parkinson's.

Nutrition and Parkinson's disease: the role of nutrition

Nutrition also plays an important role in the management of Parkinson's disease. Although there is no specific diet to prevent or cure Parkinson's disease, a balanced, nutrient-rich diet can help to Maintain brain health and reduce oxidative stress, which is one of the factors that could contribute to neuronal degeneration.

Diets rich in antioxidants, such as fruits and vegetables, can help fight free radicals and help combat oxidative stress in the brain. Omega-3 fatty acids, found, for example, in oily fish, have shown beneficial effects on the brain; they can reduce inflammation and protect neurons.

Another aspect to consider is constipation, a common problem in Parkinson's patients. A diet rich in fibers, combined with a good hydration, can alleviate this symptom, thereby improving overall well-being.

Physiotherapy and speech therapy: essential supports for quality of life

La physiotherapy is a key element in helping Parkinson's patients maintain mobility, reduce the risk of falls, and improve quality of life. Physical therapists can develop targeted exercise programs to improve balance, muscle strength and flexibility. These programs tailored to the individual patient help maintain a good level of physical function, improving patients' independence.

Also the speech therapy plays a key role, especially for patients who develop difficulties with speech or swallowing, two problems that often emerge as the disease progresses. Through specific exercises, speech therapists can help patients improve speech clarity and manage swallowing problems, preventing complications such as aspiration during meals.

Complementary therapies: an integrated approach

Many patients turn to complementary therapies to manage Parkinson's symptoms and thus improve their quality of life. These include acupuncture, meditation, music therapy, deep brain stimulation (DBS) and AMPS therapy. Although the effectiveness of some of these therapies is still being studied, many people report benefits, especially in terms of stress reduction and improved emotional well-being.

Deep brain stimulation, in particular, is a surgical procedure that involves implanting electrodes into the brain to regulate neuronal activity. This technique has been used successfully in some patients to reduce motor symptoms, especially in patients who no longer respond well to medication. However, it is an invasive procedure and not suitable for all patients.

Gondola AMPS therapy: an innovative approach

One of the most innovative complementary therapies in the treatment of Parkinson's disease is Gondola AMPS (Automated Mechanical Peripheral Stimulation). This therapy is based on mechanical stimulation of specific points in the soles of the feet, through which a pulse is sent to the brain that can help increase functional connectivity in brain areas involved in movement.

Automated mechanical stimulation is delivered by means of a medical device called the Gondola, which exerts pressure in a controlled manner on four points in the feet. This stimulation has been found to be effective in increasing stride length, stability, and speed, thereby improving walking, balance, and reducing the risk of falls.
Clinical studies, such as those of Pagnussat et al. and Quattrocchi et al., have shown that Gondola AMPS therapy not only improves walking parameters, but also stimulates brain neuroplasticity, improving connectivity between motor circuits.

In addition to being able to be used in conjunction with other therapies, such as pharmacology and physiotherapy, improving patients' overall quality of life, this treatment is noninvasive; therefore, it is a safe and well-tolerated option, reducing the risks associated with more invasive surgical procedures or interventions.

Although Gondola AMPS therapy is still a subject of study, it represents one of the new frontiers in the treatment of Parkinson's disease, offering hope to patients seeking noninvasive solutions to manage motor symptoms.

Future perspectives: Parkinson's research

The future of Parkinson's treatment could hold exciting surprises. Current research is focusing on several promising areas, such as the use of stem cells To regenerate damaged neurons, gene therapy to correct genetic defects associated with the disease and the development of new neuroprotective drugs.

Another area of great interest is that of the neuroinflammation, or inflammation of the central nervous system. Reducing inflammation could be an effective strategy to slow the progression of the disease.

In addition, the identification of early biomarkers of Parkinson's could allow earlier diagnosis and targeted interventions before motor symptoms become apparent.

Slowing the progression of Parkinson's disease is a complex challenge, but not impossible. Although there is still no definitive cure, advances in research, combined with lifestyle changes, exercise, and innovative therapies such as the AMPS Gondola Therapy, offer new hope for improving patients' quality of life.
The key to effective management of Parkinson's lies in a personalized approach that integrates medications, physical therapies, medical devices, and targeted rehabilitation strategies.

References:

1. Stocchi F, Sale P, Kleiner AF, et al. Long-term effects of automated mechanical peripheral stimulation on gait patterns of patients with Parkinson's disease. Int J Rehabil Res. 2015;38(3):238-245.
2. Barbic F, Galli M, Dalla Vecchia L, et al. Effects of mechanical stimulation of the feet on gait and cardiovascular autonomic control in Parkinson's disease. J Appl Physiol (1985). 2014;116(5):495-503.
3. Galli M, Kleiner A, Gaglione M, et al. Timed Up and Go test and wearable inertial sensor: a new combining tool to assess change in subject with Parkinson's disease after automated mechanical peripheral stimulation treatment. Int J Eng Innov Technol. 2015;4(11):155-163
4. Galli M, Vicidomini C, Rozin Kleiner AF, et al. Peripheral neurostimulation breaks the shuffling steps patterns in Parkinsonian gait: a double blind randomized longitudinal study with automated mechanical peripheral stimulation. Eur J Phys Rehabil Med. 2018;54(6):860-865.
5. Kleiner A, Galli M, Gaglione M, et al. The Parkinsonian Gait Spatiotemporal Parameters Quantified by a Single Inertial Sensor before and after Automated Mechanical Peripheral Stimulation Treatment. Parkinsons Dis. 2015;2015:390512.
6. Kleiner AFR, Souza Pagnussat A, Pinto C, Redivo Marchese R, Salazar AP, Galli M. Automated Mechanical Peripheral Stimulation Effects on Gait Variability in Individuals With Parkinson Disease and Freezing of Gait: A Double-Blind, Randomized Controlled Trial. Arch Phys Med Rehabil. 2018;99(12):2420-2429.
7. Pagnussat AS, Kleiner AFR, Rieder CRM, et al. Plantar stimulation in parkinsonians: From biomarkers to mobility - randomized-controlled trial. Restor Neurol Neurosci. 2018;36(2):195-205.
8. Pagnussat AS, Salazar AP, Pinto C, et al. Plantar stimulation alters brain connectivity in idiopathic Parkinson's disease. Acta Neurol Scand. 2020;142(3):229-238.
9. Pinto C, Pagnussat AS, Rozin Kleiner AF, et al. Automated Mechanical Peripheral Stimulation Improves Gait Parameters in Subjects With Parkinson Disease and Freezing of Gait: A Randomized Clinical Trial. Am J Phys Med Rehabil. 2018;97(6):383-389.
10. Prusch JS, Kleiner AFR, Salazar AP, et al. Automated mechanical peripheral stimulation and postural control in subjects with Parkinson's disease and freezing of gait: a randomized controlled trial. Funct Neurol. 2018;33(4):206-212.
11. Quattrocchi CC, de Pandis MF, Piervincenzi C, et al. Acute Modulation of Brain Connectivity in Parkinson Disease after Automatic Mechanical Peripheral Stimulation: A Pilot Study. PLoS One. 2015;10(10):e0137977. Published 2015 Oct 15.
12. Zamuner AR, Shiffer D, Barbic F, et al. Mechanical somatosensory stimulation decreases blood pressure in patients with Parkinson's disease. J Hypertens. 2019;37(8):1714-1721.
13. Tedeschi M, Rinaldo V, Galli M, et al. Automated mechanical peripheral stimulation for gait rehabilitation in Parkinson's disease: A comprehensive review. Clin Park Relat Disord. 2023;8:100208.
14. Wittenberg GF. Neural plasticity and treatment across the lifespan for motor deficits in cerebral palsy. Dev Med Child Neurol. 2009;51 Suppl 4:130-133.
15. Reid LB, Rose SE, Boyd RN. Rehabilitation and neuroplasticity in children with unilateral cerebral palsy. Nat Rev Neurol. 2015;11(7):390-400.